LAKE OSWEGO, Ore.--(BUSINESS WIRE)--Calypte Biomedical Corporation (OTCBB: CBMC), a manufacturer and marketer of medical diagnostic tests for the rapid detection of antibodies to the human immunodeficiency virus (HIV), announced today that it will hold a conference call for the investment community and other interested parties on Tuesday, September 18, 2007 to discuss a significant corporate development. The Company will issue a press release disclosing the development prior to the opening of the stock market.
